When age may prompt a DEXA scan

A clinician may suggest assessment earlier than routine age-based screening when medical history, medicines, hormonal changes, or a low-impact fracture indicate possible loss of bone strength.

DEXA uses low-dose X-rays to estimate bone mineral density, usually at the hip and lower spine. The result helps a clinician assess bone strength and future fracture risk; it is interpreted with age, sex, body build, health history, and previous fractures rather than in isolation.

Reasons to consider testing sooner can include premature ovarian insufficiency or early menopause, long-term use of medicines that weaken bone, conditions that reduce nutrient absorption, substantial loss of height, or a fracture after a minor fall. The presence of a risk factor does not automatically mean osteoporosis, but it can make testing useful.

Bring a list of prescribed and non-prescribed medicines, details of previous fractures, menstrual or menopause history when relevant, and any family history of hip fracture. Mention digestive, thyroid, kidney, inflammatory, or hormonal conditions because they may change the assessment.

Before booking a scan independently, confirm whether the result would change care. A clinician can also discuss weight-bearing activity, resistance exercise, fall prevention, nutrition, smoking, and alcohol as they relate to your circumstances.

A DEXA scan is generally planned rather than urgent. Seek prompt assessment after a fall if you cannot bear weight, have severe pain, notice a limb that appears shortened or misshapen, or develop new weakness or numbness. Sudden severe back pain, especially after a minor strain or fall, also needs clinical assessment.

Arrange a routine review if you have become shorter, developed a stooped posture, or experienced a low-impact fracture. These changes can influence whether imaging or bone-density testing is appropriate.

Ask which personal factors support testing now, what areas will be scanned, how the result will be interpreted for your age, and whether it would change treatment. If repeat testing is proposed, ask what change is being monitored and when another result would be clinically useful.